A detailed history of Darwin Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Darwin Advisors, LLC holds 24,636 shares of BSX stock, worth $2.52 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
24,636
Holding current value
$2.52 Million
% of portfolio
0.58%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$72.96 - $84.0 $1.8 Million - $2.07 Million
24,636 New
24,636 $2.06 Million
Q2 2020

Aug 06, 2020

SELL
$30.19 - $39.11 $36,228 - $46,932
-1,200 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$25.83 - $45.71 $30,995 - $54,852
1,200 New
1,200 $39,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.